The common regulatory pathway of MHC class I and class II transactivation

Microbes and Infection

Volumn 1, Issue 11, 1999, Pages 887-892

  Van Den Elsen, Peter J ^a   Gobin, Sam J P ^a  

^a Division of Molecular Biology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR;

COMPLEX FORMATION; DNA SEQUENCE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TRANSACTIVATION;

EID: 0032742329     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00229-4     Document Type: Article

References (35)

1. Mach B., Steimle V., Martinez-Soria E., Reith W. Regulation of MHC class II genes: lessons from a disease. Ann. Rev. Immunol. 14:1996;301-331.
2. Boss J.M. Regulation of transcription of MHC class II genes. Curr. Op. Immunol. 9:1997;107-113.
3. Moreno C.S., Rogers E.M., Brown J.A., Boss J.M. Regulatory factor X a bare lymphocyte syndrome transcription factor is a multimeric phosphoprotein complex. J. Immunol. 158:1997;5841-5848.
4. Masternak K., Barras E., Zufferey M., Conrad B., Corthals G., Aebersold R., Sanchez J.C., Hochstrasser D.F., Mach B., Reith W. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20:1998;273-277.
5. Nagarajan U.M., Louis-Plence P., Desandro A., Nilsen R., Bushey A., Boss J.M. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome an MHC class II immunodeficiency. Immunity. 10:1999;153-162.
6. Steimle V., Durand B., Barras E., Zufferey M., Hadam M., Mach B., Reith W. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome. Genes Dev. 9:1995;1021-1032.
7. Durand B., Sperisen P., Emery P., Barras E., Zufferey M., Mach B., Reith W. RFXAP a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 16:1997;1045-1055.
8. Moreno C.S., Beresford G.W., Louis-Plence P., Morris A.C., Boss J.M. CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity. 10:1999;143-151.
9. Louis-Plence P., Moreno C.S., Boss J.M. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes. J. Immunol. 159:1997;3899-3909.
10. Gobin S.J.P., Peijnenburg A., Van Eggermond M., Van Zutphen M., Van den Berg R., Van den Elsen P.J. The RFX complex is crucial for the constitutive and CIITA mediated transactivation of MHC class I and β2-microglobulin genes. Immunity. 9:1998;531-541.
11. Hooft Van Huijsduijnen R., Li X.Y., Black D., Matthes H., Benoist C., Mathis D. Co-evolution from yeast to mouse: cDNA cloning of the two NF-Y (CP-1/CBF) subunits. EMBO J. 9:1990;3119-3127.
12. Zeleznik-Le N., Azizkhan J.C., Ting J.P.-Y. Affinity purified CCAAT-box-binding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA. 88:1991;1873-1877.
13. Tsang S.Y., Nakanishi M., Peterlin B.M. Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors. Mol. Cell. Biol. 10:1990;711-719.
14. Jabrane-Ferrat N., Fontes J.D., Boss J.M., Peterlin B.M. Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions. Mol. Cell. Biol. 16:1996;4683-4690.
15. Fontes J.D., Jabrane-Ferrat N., Peterlin B.M. Assembly of functional regulatory complexes on MHC class II promoters in vivo. J. Mol. Biol. 75:1997;336-345.
16. Steimle V., Otten L.A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome. Cell. 75:1993;135-146.
17. Riley J.L., Westerheide S.D., Price J.A., Brown J.A., Boss J.M. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity. 2:1995;533-543.
18. Zhou H., Glimcher L.H. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA one of the defective genes in type II MHC combined immune deficiency. Immunity. 2:1995;545-553.
19. Scholl T., Mahanta S.K., Strominger J.L. Specific complex formation between type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA. 94:1997;6330-6334.
20. 32. Nucl. Acids Res. 25:1997;2522-2528.
21. Mahanta S.K., Scholl T., Yang F.C., Strominger J.L. Transactivation by CIITA the type II bare lymphocyte syndrome-associated factor requires participation of multiple regions of the TATA box binding protein. Proc. Natl. Acad. Sci. USA. 94:1997;6324-6329.
22. LeBouteiller P. HLA class I chromosomal region genes and products: facts and questions. Crit. Rev. Immunol. 14:1994;89-129.
23. Gobin S.J.P., Keijsers V., Van Zutphen M., Van den Elsen P.J. The role of enhancer A in the locus-specific transactivation of classical and non-classical HLA class I genes by NF-B. J. Immunol. 161:1998;2276-2283.
24. Van den Elsen P.J., Gobin S.J.P., Van Eggermond M.C.J.A., Peijnenburg A. Regulation of MHC class I and II transcription: differences and similarities. Immunogenetics. 48:1998;208-221.
25. Johnson D.R., Pober J.S. HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. Mol. Cell. Biol. 14:1994;1322-1332.
26. Drew P.D., Guido F., Becker K.G., Bours V., Carlson L.M., Siebenlist U., Ozato K. NFκB and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. J. Interferon Cytokine Res. 15:1995;1037-1045.
27. Gobin S.J.P., Peijnenburg A., Keijsers V., Van den Elsen P.J. Site d is crucial for two routes of IFNγ-induced MHC class I transactivation: The ISRE-mediated route and a novel pathway involving CIITA. Immunity. 6:1997;601-611.
28. Schoneich J., Lee J.L., Mansky P., Sheffery M., Yang S.Y. The pentanucleotide ATTGG the 'inverted CCAAT' is an essential element for HLA class I gene transcription. J. Immunol. 158:1997;4788-4796.
29. Van den Elsen P.J., Peijnenburg A., Van Eggermond M.C.J.A., Gobin S.J.P. Shared regulatory elements in the promoters of MHC class I and class II genes. Immunol. Today. 19:1998;308-312.
30. Martin B.K., Chin K.C., Olsen J.C., Skinner C.A., Dey A., Ozato K., Ting J.P.-Y. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity. 6:1997;591-600.
31. Reith W., Siegrist C.A., Durand B., Barras E., Mach B. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA. 91:1994;554-558.
32. Wright K.L., Vilen B.J., Itoh-Lindstrom Y., Moore T.L., Li G., Criscitiello M., Cogswell P., Clarke J.B., Ting J.P.-Y. CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors. EMBO J. 313:1994;4042-4053.
33. Kobr M., Reith W., Herrero-Sanchez C., Mach B. Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family. Mol. Cell Biol. 10:1990;965-971.
34. Hasegawa S., Boss J. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters. Nucleic Acids Res. 19:1991;6269-6276.
35. Ono S.J., Song Z. Mapping of the interaction site of the defective transcription factor in the Class II major histocompatibility complex mutant cell line clone-13 to the divergent X2-Box. J. Biol. Chem. 270:1995;6396-6402.